Acurx Pharmaceuticals (ACXP) Tops Q3 EPS by 2c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q3 EPS of ($0.32), $0.02 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
• Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs